MedPath

Effectiveness of rebamipide for human gastric membrane after distal gastrectomy

Not Applicable
Conditions
Gastritis in remnant stomach
Registration Number
JPRN-UMIN000002068
Lead Sponsor
Chiba University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients treated with gastric secretion inhibitor in a month prior to this study. 2.Patients with thoracotomy, hepatectomy, pancreatomy or colectomy. 3.Patients with other malignancy. 4.Patients with cardiac, hepatic or hematologic disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patient number with gastritis or inflammatory change in remnant stomach
Secondary Outcome Measures
NameTimeMethod
oss of body weight
© Copyright 2025. All Rights Reserved by MedPath